RelB suppresses type I Interferon signaling in dendritic cells

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Type I Interferon (IFN) signaling is crucial for dendritic cell (DC) development and function.
• Hyperactive type I IFN signaling can impede the development of the cDC2 subtype.
• Relb is a known transcription factor essential for cDC2 development.

Purpose of the Study:

• To investigate the role of Relb in modulating type I IFN signaling within dendritic cells.
• To understand the molecular mechanisms by which Relb influences IFN responses.
• To determine the impact of Relb on cDC2 development in the context of IFN signaling.

Main Methods:

• Analysis of type I IFN signaling in Relb-expressing and Relb-deficient dendritic cells (FL-DCs, cDC2 cultures).
• Assessment of Interferon-Stimulated Genes (ISGs) and IκBα levels.
• Utilizing Ifnar1 knockout mice to study cDC2 development in the absence of IFN signaling.

Main Results:

• Relb suppresses homeostatic type I IFN signaling in cDC2 cultures.
• TLR stimulation induced RelB, which correlated with decreased IFN signatures and ISG levels.
• Relb's inhibitory effect on IFN signaling is mediated by increased IκBα levels.
• Relb deficiency led to dampened antiviral responses due to elevated ISG levels.
• cDC2 developmental defects in Relb null mice were rescued in an Ifnar1-deficient background.

Conclusions:

• Relb functions as a novel negative regulator of the type I IFN signaling pathway.
• Relb fine-tunes type I IFN signaling, impacting dendritic cell development, particularly the cDC2 subtype.
• This study elucidates a new mechanism controlling immune homeostasis and DC subtype differentiation.